ABSTRACT-We purified macrophage migration inhibitory factor/glycosylation inhibiting factor (MIF/GIF) from bovine brain by using an affinity column with the C-terminal region peptide of a novel serpin as a ligand. The affinity purified preparation showing a single band on SDS-PAGE contained four peptides on RP-HPLC, which were converged into two peptides time-dependently. Sequence analysis and Western blotting revealed that one was identical to bovine MIF/GIF and the other was an N-terminally modified form of MIF/GIF. These results indicated that there exist at least two forms of MIF/GIF in the bovine brain and that they have an affinity for the C-terminal portion of the serpin.
Macrophage migration inhibitory factor (MIF) was first characterized as a lymphokine produced by activated T-lymphocytes (1, 2). Functional expression cloning from activated human T-lymphocytes identified cDNA en coding a protein with MIF activity (3). Calandra et al. (4) demonstrated that MIF was also synthesized in the cells of monocyte/macrophage lineage and upon stimulation with bacterial lipopolysaccharide (LPS), tumor necrosis factor (TNF)-a and interferon-r, MIF was released from these cells. MIF in turn induced the release of TNF-a from macrophages through autocrine and paracrine mechanisms (3). Thus, MIF seems to be one of the critical cytokines in the host defense mechanism. Northern blot analysis showed that MIF was expressed in various tissues beyond the immune system (5-7), suggesting the widespread role of this cytokine. In fact, it was reported that MIF was released from the pituitary as a hormone after the injection of LPS into mice, contributing to the toxic response to endotoxemia (8, 9) .
Recently, we purified a novel member of the serine proteinase inhibitor (serpin) family from the bovine brain (10). A serpin named B-43 from its molecular mass, was homologous to glia-derived nexin-1/protease nexin-1, plasminogen activator inhibitor-2, leukocyte elastase in hibitor and placental thrombin inhibitor, but had differ ent biochemical properties from them. We synthesized a peptide corresponding to the C-terminal region of B-43, which is a part of the peptide possibly cleaved from native serpin by target serine proteinases and contains the hydrophobic amino acid sequence suggested as a ligand for receptors of the serpin-serine proteinase complex and amyloid ~-peptide (11). During the search for the putative target proteinase by using an affinity column with this synthetic peptide as a ligand, we found binding proteins to the peptide and identified them as cytokine MIF and its N-terminally modified protein.
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The fresh bovine brain was obtained from a slaughter house. The whole brain (about 400 g) was homogenized with 1.21 of 20 mM imidazole-HC1 buffer, pH 7.2, con taining 1 mM EDTA, 1 mM EGTA and 1 mM phenyl methylsulfonyl fluoride (buffer A) in a Waring blender. The homogenate was centrifuged at 25,000 x g for 50 min. The resulting supernatant was applied to a peptide (LMVVPRFNANHPFLFFIQHSKT)-conjugated Affigel 10 (Bio-Rad, Richmond, CA, USA) column (8-ml bed volume) equilibrated with buffer A. The column was successively washed with 300 ml of buffer A, 100 ml of 1 M NaCl in buffer A, 60 ml of 6 M urea in buffer A and 60 ml of 20 mM sodium citrate buffer, pH 3.2. Finally, bound proteins were eluted with 6 M urea in 20 mM sodium citrate buffer, pH 3.2 (fraction numbers 64-69 in Fig. IA ). The affinity purified proteins were applied to RP-HPLC (ODS-H 5 pm, 4.6 x 150 mm; Chemcosorb, Osaka) and eluted with a linear gradient of acetonitrile in 0.1% trifluoroacetic acid (Fig. 1C) . According to the retention time, we named the four peaks peptide 1 to peptide 4. Peptide 2 and peptide 4 were treated with endopeptidase (Lys-C; Boehringer Mannheim, Tokyo) or BrCN. The digest was applied to the HPLC column described above, and the collected peptides were analyzed by an automated protein sequencer (ABI477A/120A; Applied Biosystems, Foster City, CA, USA). HPLC purified peptide 2 (100 pg) in PBS was used for the immunization of rabbits (Seiwa Experimental Animals, Fukuoka). The protocol of immunization was described previously (12). As shown in Fig. IA , the proteins bound to a peptide (LMVVPRFNANHPFLFFIQHSKT)-conjugated affinity column were eluted with 6 M urea at pH 7.2 (fraction numbers 46-52 in Fig. IA) and at pH 3.2 (fraction num bers 64-69 in Fig. IA) , after extensive washing with the equilibration buffer and 1 M NaCl. The fractions eluted with 6 M urea at pH 7.2 contained several proteins on SDS-PAGE, while the latter fractions contained a single band on SDS-PAGE (Fig. 1B) . The apparent molecular mass of the protein eluted at pH 3.2 was about 10 kDa under reducing and nonreducing conditions. The 10-kDa band was separable into four peaks (peptide 1 to peptide 4) on RP-HPLC eluted with a linear gradient of acetoni trile (Fig. 1C) ; and the four peptides were converged into two peaks, peptide 2 and peptide 4, within one week after the purification at 4C. The complete protein sequencing of peptide 2 and the homology search showed that pep tide 2 was identical to bovine brain MIF/glycosylation inhibition factor (GIF) protein (13) and was highly homologous to MIF/GIF from other species (3, 7, 14) ( Fig. 2) . The blank position of signals in peptide 2 cor responds to the cysteine residue in MIF/GIF from differ ent sources. GIF was reported to suppress the synthesis of IgE through the inhibition of glycosylation of IgE bind ing protein (14). Peptide 1 had the same N-terminal amino acid sequence as peptide 2 (Pro' .. Ala27). Peptides 3 and 4 were N-terminally blocked. The partial amino acid se quence of peptide 4 after the cleavage by Lys-C endopep tidase indicated that peptide 4 had the same sequence as peptide 2 (Pro" • .. Iso '). Anti-peptide 2 antiserum recog nized four peptides on Western blotting (Fig. 1D) . These results as a whole indicated that the affinity purified pro teins were MIF/GIF, and its N-terminally modified form and that either of them had conformational variants. (14). dDeduced from the murine MIF (mMIF) cDNA sequence (7). Deduced from the chicken MIF (cMIF) cDNA sequence (7). Galat et al. (13, 15) purified two species of MIF/GIF molecule having different isoelectric points, 9.4 and 9.5, by using chromatofocusing and ion exchange chromato graphies. Since both species with different p1 values were not N-terminally blocked, they may correspond to pep tide 1 and peptide 2 in the present study.
The peptide used as a ligand for the affinity column is derived from the sequence of a novel serpin (B-43) purified from bovine brain and corresponds to a part of the peptide sequence released from native B-43 by puta tive proteinases (10). The interaction between the serpin derived peptide and MIF/GIF proteins must be strong and specific because the bound proteins were only eluted after extensive washing with 1 M NaCl and 6 M urea at pH 7.2 and because there was no protein recovered when we used an Affigel 10 column without ligand. Recently we observed that B-43 formed an SDS-stable complex with thrombin (unpublished observation), strongly suggesting that B-43 was an inhibitor of thrombin present in the brain. Therefore, it is very important to examine whether MIF/GIF has any influence on the formation of the com plex between B-43 and the proteinase. Lanahan et al. (5) and Paralkar and Wistow (6) demonstrated the high expression of MIF mRNA in the brain among the tissues examined. It has been reported that MIF is a hormonal factor released from the anterior pituitary after the challenge with LPS, exacerbating endo toxemia (8, 9); However, little is known about the role of MIF/GIF in the brain except for the pituitary. As a serine proteinase and the serpin system has been sug gested to be involved in neuronal degeneration, repair and plasticity, the interaction between MIF/GIF and a peptide derived from B-43 may play a role in this context. Identification of the binding peptide to MIF/GIF will promote the studies on this cytokine in the brain. B-43 was demonstrated to be present in pyramidal cells of the bovine cerebral cortex and glial fibrillary acidic protein positive astrocytes in the white matter of the cerebrum (12). The cellular localization of MIF/GIF in the brain should be clarified.
